China Resources in talks to take Sihuan Pharma private at $3 bln valuation -sources
State conglomerate China Resources is in early-stage talks with Sihuan Pharmaceutical’s (0460.HK) chairman about jointly taking the Hong Kong-listed company private in a deal valuing it at nearly $3 billion, two people with knowledge of the matter said.
Exclusive: Pfizer to cut U.S. sales staff as meetings with healthcare providers move to virtual
Pfizer Inc (PFE.N) said on Tuesday it is reducing its U.S. sales staff as it expects doctors and other healthcare providers to want fewer face-to-face interactions with sales people after the COVID-19 pandemic ends.
New York, drug distributors reach $1.18 bln opioid settlement as national deal looms
The three largest U.S. drug distributors agreed mid-trial to pay up to $1.18 billion to settle claims by New York state and two of its biggest counties over their role in the nationwide opioid epidemic, the state’s attorney general said on Tuesday.
European shares fall on inflation, pandemic woes
European shares fell on Wednesday as worries about rising inflation and the Delta variant of the novel coronavirus hit economically sensitive sectors, even as technology stocks tracked an overnight surge in their U.S. peers.
Top scientists question the need for COVID-19 booster shots
COVID-19 vaccine developers are making ever bolder assertions that the world will need yearly booster shots, or new vaccines to tackle concerning coronavirus variants, but some scientists question when, or whether, such shots will be needed. In interviews with Reuters, more than a dozen influential infectious disease and vaccine development experts said there is growing […]
